Apotex Health Corp. completes a Toronto initial public offering priced at the top of its marketing range, according to Bloomberg. The company had been guiding investors to price the IPO at the upper end of the stated range later Tuesday, based on people familiar with the matter. In the pricing, Apotex and some of its backers raise a total of about C$1.3 billion (approximately $932 million), the sources say. The deal is described as the largest Canadian IPO since 2021. The reports cover the share sale timing and the final pricing outcome versus the initial marketing guidance, and they attribute the fundraising amount to both Apotex and participating backers. No additional details on the number of shares, specific offering size beyond the total proceeds, or the valuation are included in the provided excerpts.